The Saudi Arabia Diabetes Devices Market is Segmented Into Device Category (Monitoring Devices and Management Devices), End User (Hospitals & Clinics, Home-Care Settings, and Retail Pharmacies & Diabetes Centers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce / Online Pharmacies), and Diabetes Type (Type-1 Diabetes, Type-2 Diabetes, and Gestational & Other Specific Types)

The size of the Saudi Arabia Diabetes Care Devices Market market was valued at USD 665.10 Million in 2023 and is projected to reach USD 894.85 Million by 2032, with an expected CAGR of 4.33% during the forecast period. The Saudi Arabia Diabetes Care Devices Market is therefore on an upward trajectory in terms of growth due to factors such as increased prevalence of diabetes, growing population of senior citizens as well as rising cases of obesity. The devices include blood glucose meter, insulin pen, continuous glucose monitors abbreviated as CGM, test strips that help in diabetes. Education programs supported by the government, increased funding of health care facilities, and other related awareness campaigns have created awareness towards preventing and controlling diabetes. Recent innovations are seen in mobile app compatible diabetes devices that form the key trends in the diabetes management market which include wearable monitoring systems. So, the move toward patient self-care and the development of peripheral diagnostics enhance the need for diabetes care devices in Saudi Arabia. Recent developments include: July 2022: Under Vision 2030, the Saudi Arabian government plans to invest over USD 65 billion to develop the country's healthcare infrastructure. In addition, it aimed to increase the private sector's contribution from 40 percent to 65 percent by 2030, targeting the privatization of 290 hospitals and 2,300 primary health centers., May 2022: Tamer, the Middle East's healthcare distribution company, has agreed on a 5-year deal to bring Huma's technology platform to power 'hospitals at home' with remote patient monitoring to the 34 million people living in the Kingdom of Saudi Arabia. The new health program was to begin with support for patients with diabetes and cardiovascular disease.. Key drivers for this market are: Rising Prevalence of Cancer Worldwide, Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment. Potential restraints include: High Cost of Molecular Diagnostic Tests, Lack of Skilled Workforce and Stringent Regulatory Framework. Notable trends are: Monitoring Devices Segment Expected to Register Significant Growth.

The Saudi Arabia Diabetes Devices Market size was valued at USD 199.6 million in 2023 and is projected to reach USD 345.20 million by 2032, exhibiting a CAGR of 8.14 % during the forecasts period. Saudi Arabia diabetes devices are medical devices used to diagnose, control, prevent, and treat diabetes mellitus in patients. Such devices include blood glucose meters, CGMs, insulin pumps, and insulin pens used by people with diabetes. These devices are related to the constant measurement of blood glucose levels and controlling diabetes using insulin and other symptoms associated with it. Examples include inpatient, outpatient, and community care settings such as hospitals, outpatient pharmacies, and self-care settings in cases of diabetes. Some of the patterns shaping the market are the emerging focuses in extended wearables for CGM, digital health adoption for Home & Remote Monitoring and Telemedicine, and the rise in Insulin Delivery Systems for Personalized Diabetes Management. New cases of diabetes, focusing on the healthcare system improvement by the government, and a growing number of people who have enhanced awareness of the condition drive the growth of the Saudi Arabia diabetes devices market. Recent developments include: In February 2023, Insulet Corporation acquired the assets of a California-based company, Automated Glucose Control LLC (AGC), specializing in automated insulin delivery technology , In February 2023, Insulet Corporation acquired the patents for insulin pumps from Bigfoot Biomedical (Bigfoot), a company specializing in insulin delivery technologies , In August 2022, Abbott entered a strategic agreement with WW International, Inc. (WeightWatchers). With the help of this partnership, both companies will combine WeightWatchers weight management program for people with diabetes with Abbott's line of FreeStyle Libre products to produce a seamless mobile experience, offering knowledge & insights to improve their diet, lower their blood sugar levels, and, ultimately, take back control of their health , In August 2022, Insulet Corporation received FDA clearance for its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged 2 and above with type 1 diabetes .

The Saudi Arabia Diabetes Devices Market was valued at USD 200.72 Million in 2024 and is projected to grow to USD 325.66 Million by 2030, with a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.

Saudi Arabia diabetes care devices market is estimated to grow a robust CAGR of 6.1% during 2025-2032, driven by increasing diabetes cases in the country

The Middle East And Africa Diabetes Care Devices Market report segments the industry into Monitoring Devices (Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices), Management Devices (Insulin Pumps, Insulin Syringes, Insulin Disposable Pens, Insulin Cartridges In Reusable Pens, Jet Injectors), and Geography (Saudi Arabia, Iran, Egypt, Oman, South Africa, Rest Of Middle East And Africa).

The Middle East and Africa Diabetes Care Devices market, valued at $2.43 billion in 2025, is projected to experience robust growth, driven by rising diabetes prevalence, increasing healthcare expenditure, and expanding awareness of diabetes management. The market's Compound Annual Growth Rate (CAGR) of 4.12% from 2025 to 2033 indicates a significant expansion in market size over the forecast period. Key growth drivers include the increasing adoption of advanced continuous glucose monitoring (CGM) systems offering improved glycemic control, the rising affordability of insulin pumps and other management devices, and governmental initiatives focused on improving diabetes care infrastructure across the region. Growth is further fueled by the increasing prevalence of type 2 diabetes, linked to lifestyle changes such as urbanization and dietary shifts. While challenges remain, such as affordability constraints in certain segments of the population and limited healthcare access in some regions, these are being offset by technological advancements and government interventions aimed at improving healthcare accessibility. The market segmentation highlights the significant contribution of self-monitoring blood glucose devices (SMBG), particularly glucometers and test strips, alongside the growing adoption of CGMs and insulin pumps which represent premium segments with high growth potential. Geographically, countries like Saudi Arabia, Iran, and Egypt are expected to dominate the market due to their high diabetes prevalence and relatively developed healthcare infrastructure. The competitive landscape is marked by the presence of major multinational players like Dexcom, Medtronic, Roche, and Novo Nordisk, alongside several regional companies. These companies are strategically investing in R&D, product innovation, and expansion of their distribution networks to cater to the diverse needs of the market. The continuous innovation in device technology, focusing on improved accuracy, convenience, and patient-centric design, will further stimulate market growth. Future market dynamics will likely be shaped by the increasing adoption of telehealth and remote monitoring technologies, the development of closed-loop insulin delivery systems, and the expanding role of digital health solutions in diabetes management. This trend towards personalized and technologically advanced diabetes care is set to drive further growth and transformation within the Middle East and Africa Diabetes Care Devices market in the coming years. Recent developments include: August 2023: Nemaura Medical has received approval from the Saudi Food and Drug Authority (SFDA) for its non-invasive wearable glucose sensor, sugarBEAT. This approval follows more than a year of partnership with the SFDA through the company’s licensee in the Middle East, TPMENA, from which Nemaura previously received a provisional purchase order for 1.7 million sensors and 17,000 devices., October 2022: Becton, Dickinson, and Company and Biocorp announced that they signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies would integrate Biocorp's Injay technology-a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes.. Notable trends are: Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period.

The size of the Saudi Arabia Self-Monitoring Blood Glucose Devices Market was valued at USD 117 Million in 2023 and is projected to reach USD 180.86 Million by 2032, with an expected CAGR of 6.42% during the forecast period. Growth in the Saudi Arabia Self-Monitoring Blood Glucose Devices market can be attributed to the increasing prevalence of diabetes and increasing awareness of self-care among patients. Self-Monitoring Blood Glucose Devices are medical devices that enable patients to measure their blood sugar levels in the comfort of home. It is an important part of diabetic management as it enables the tracking of a patient's glucose levels and monitoring of the insulin dosage required; this information will drive the decisions regarding diet and exercise. The SMBGs are highly in use throughout the country among the diabetic population in Saudi Arabia. These machines give the patients much control over their health condition, thus preventing complications of hypoglycemia and hyperglycemia. Through frequent checking and adjustment of their blood glucose levels, patients prevent inappropriate aggravation of the disease processes. SMBG allows individuals to be preventive of their diabetes, meaning they are able to enjoy a better quality of life while being cost-effective as well as effective in management. Recent developments include: January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes-one of the largest combined blood glucose meter and mobile diabetes app datasets ever published., January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The hand-held Cobas Pulse included an automated glucose test strip reader as well as a camera and touchscreen for logging other diagnostic results. It was designed to be used with patients of all ages, including neonates and people in intensive care.. Key drivers for this market are: Rising Prevalence of Cancer Worldwide, Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment. Potential restraints include: High Cost of Molecular Diagnostic Tests, Lack of Skilled Workforce and Stringent Regulatory Framework. Notable trends are: Rising Diabetes Prevalence in Saudi Arabia.

The Saudi Arabia blood glucose monitoring devices market size reached USD 188.14 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 354.71 Million by 2033, exhibiting a growth rate (CAGR) of 6.80% during 2025-2033. The market is growing significantly due to the rising prevalence of diabetes, growing health awareness, and rapid technological advancements. Additionally, favorable government policies are anticipated to maintain market's expansion and innovation in the upcoming years.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on device and end user.

The Middle East and Africa Continuous Glucose Monitoring (CGM) market is experiencing robust growth, projected to reach $261.03 million by 2025 and maintain a Compound Annual Growth Rate (CAGR) of 12.83% from 2025 to 2033. This expansion is driven by several key factors. Rising prevalence of diabetes, particularly in countries like Saudi Arabia, Egypt, and Iran, fuels the demand for advanced glucose management solutions. Increased awareness of the benefits of CGM systems, such as improved glycemic control and reduced risk of complications, is also a significant driver. Furthermore, the growing adoption of telehealth and remote patient monitoring technologies is facilitating greater access to CGM and enhancing patient outcomes. The market is segmented by components (sensors, durables), distribution channels (online, offline), and geography, offering various avenues for growth. Leading players like Abbott Diabetes Care, Dexcom, and Medtronic are actively investing in product innovation and market expansion to capitalize on the significant market opportunity. Competitive pricing strategies and the introduction of user-friendly, technologically advanced devices are contributing to market expansion. While challenges like high cost of CGM systems and limited healthcare infrastructure in some regions exist, the overall market outlook remains positive, suggesting continued strong growth in the coming years. The market's regional performance is expected to vary. Saudi Arabia, with its well-established healthcare infrastructure and high diabetes prevalence, is likely to be a key contributor to market growth. Iran and Egypt, despite having relatively lower healthcare spending per capita, are anticipated to experience significant CGM adoption due to an increasing diabetic population and the rising accessibility of affordable solutions. South Africa and other regions in sub-Saharan Africa present considerable opportunities albeit slower growth due to socioeconomic factors and healthcare access challenges. The market will witness a surge in demand for both online and offline distribution channels to cater to diverse consumer preferences and regional specificities. Technological advancements, such as the development of smaller, less invasive sensors and improved data analytics capabilities, are poised to further drive market expansion. Furthermore, increased collaboration between manufacturers, healthcare providers, and government agencies can facilitate wider adoption of CGM and improved diabetes management across the Middle East and Africa. Recent developments include: February 2023: Dexcom announced the launch of Dexcom G7 Continuous Glucose Monitoring in South Africa. The Dexcom G7 includes the Dexcom Share and Follow feature. The user of the Dexcom Follow app can also create customizable alerts and alarms. Additionally, the G7 system provides a more comprehensive view of glucose levels over time, giving people with diabetes and their healthcare providers more information to make decisions about treatment and diabetes management., June 2022: Abbott announced that it's developing a new bio-wearable that would continuously monitor glucose and ketone levels in one sensor. The glucose-ketone sensor was expected to be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring sensor, and will connect to Abbott's digital ecosystem, including personal and caregiver mobile apps and cloud-based data management software for remote monitoring by healthcare professionals.. Notable trends are: The sensors segment holds the highest market share in the Middle East and African Continuous Glucose Monitoring Market in the current year.

The size of the Middle East and Africa Continuous Glucose Monitoring Market was valued at USD 261.03 Million in 2023 and is projected to reach USD 607.66 Million by 2032, with an expected CAGR of 12.83% during the forecast period. The MEA Continuous Glucose Monitoring (CGM) market has been growing at a moderate level due to the growing incidence of diabetes in different nations such as Saudi Arabia, South Africa, and UAE. Other related devices include CGM devices that help the diabetic patient to continually get real time glucose reading hence easing the management of the condition. The adoption is growing due to an individuals’ knowledge of the newest technologies around diabetes management and because of the increased spending on healthcare infrastructure. However, there is high cost of the technology, restricted access to remote area and the legal restraints that are there even today. Other trends are the alliances of overseas health care organizations with domestic counterparts for increasing the coverage of CGM solutions. Recent developments include: February 2023: Dexcom announced the launch of Dexcom G7 Continuous Glucose Monitoring in South Africa. The Dexcom G7 includes the Dexcom Share and Follow feature. The user of the Dexcom Follow app can also create customizable alerts and alarms. Additionally, the G7 system provides a more comprehensive view of glucose levels over time, giving people with diabetes and their healthcare providers more information to make decisions about treatment and diabetes management., June 2022: Abbott announced that it's developing a new bio-wearable that would continuously monitor glucose and ketone levels in one sensor. The glucose-ketone sensor was expected to be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring sensor, and will connect to Abbott's digital ecosystem, including personal and caregiver mobile apps and cloud-based data management software for remote monitoring by healthcare professionals.. Key drivers for this market are: Rapidly Increasing Incidence and Prevalence of Diabetes, Technological Advancements in the Market. Potential restraints include: Monopolized Supply Chain and High Cost of Devices. Notable trends are: The sensors segment holds the highest market share in the Middle East and African Continuous Glucose Monitoring Market in the current year.

The size of the Hospital Supplies Market in Saudi Arabia market was valued at USD 1.06 Million in 2023 and is projected to reach USD 1.57 Million by 2032, with an expected CAGR of 5.80% during the forecast period. The hospital supplies market in Saudi Arabia is a rapidly growing sector, fueled by the country’s ongoing healthcare infrastructure development and its commitment to providing high-quality medical services. As Saudi Arabia works toward its Vision 2030 initiative, healthcare has emerged as a priority, with significant investments in hospitals, clinics, and medical facilities. The hospital supplies market encompasses various products, including medical consumables, surgical instruments, patient care equipment, infection control products, and diagnostic tools. Saudi Arabia’s aging population is leading to an increased prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer. This trend is driving demand for hospital supplies, particularly those related to long-term patient care, diagnostics, and chronic disease management. Recent developments include: In November 2022, on-site healthcare management service provider Saudi Response Plus Medical launched a specialized ambulance center and medical training center in Riyadh within just three years of entering the Saudi market., In July 2022, the Saudi Red Crescent Authority and The Helicopter Company, fully owned by the Saudi Public Investment Fund (PIF), signed an agreement for the inauguration of the Saudi Air Ambulance Service in the Kingdom. The Service has been launched in Riyadh and will expand throughout the Kingdom in several phases.. Key drivers for this market are: The Saudi government has significantly increased its healthcare budget to improve access to medical services and reduce reliance on foreign healthcare providers. This includes procurement of essential hospital supplies to ensure the highest standards of patient care. . Potential restraints include: A significant portion of Saudi Arabia’s hospital supplies is imported from international markets, making the industry vulnerable to global supply chain disruptions, currency fluctuations, and trade regulations. . Notable trends are: Saudi Arabia is embracing digital health technologies, and hospitals are increasingly adopting smart devices for patient monitoring, diagnostics, and telemedicine services. This trend is driving demand for hospital supplies that support these digital health applications. .

The Saudi Arabia In-Vitro Diagnostics Market Report is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno-Diagnostics, and More), Product (Instruments, Reagents and Kits), Usability (Disposable IVD Devices and Re-Usable IVD Devices), Application (Infectious Disease, Diabetes, and More), and End-User (Diagnostic Laboratories, Hospitals and More). The Market Forecasts are Provided in Terms of Value (USD).

Saudi Arabia Syringe Market was valued at USD 0.26 billion in 2023 and and is expected to reach USD 0.42 billion by 2029 with a CAGR of 8.63% during the forecast period.

Explore the Digital Therapeutics Market, projected to grow from USD 6.7 Bn in 2025 to USD 42.1 Bn by 2035 at an 18.5% CAGR. Discover key trends and outlook.

Snapshot img

Middle East and Africa Adult Diapers Market Size 2024-2028

The Middle East and Africa adult diapers market size is forecast to increase by USD 123.5 million at a CAGR of 4.11% between 2023 and 2028.

The market is witnessing significant growth due to increasing awareness and adoption in developing countries. Another trend driving market growth is the rise in online sales of personal hygiene products. However, volatility in raw material prices poses a challenge to market growth. Growing populations In these regions, particularly in countries like Egypt, South Africa, and Saudi Arabia, are leading to an increase In the number of elderly individuals and individuals with disabilities, thereby fueling demand for adult diapers. Absorbent materials, such as non-woven fabrics and fibers, are being used to enhance the product's absorbency and durability while minimizing the use of disposable materials. Additionally, the convenience and discretion offered by adult diapers are leading to their increasing popularity, especially among busy working professionals and individuals with active lifestyles. Despite these growth factors, market growth may be hindered by the volatility in raw material prices, particularly for materials like superabsorbent polymers and polypropylene, which are essential components of adult diapers. 

What will be the size of the Middle East and Africa Adult Diapers Market during the forecast period?

Request Free Sample

The market caters to the growing demand for incontinence absorbent products among the geriatric population and individuals with neurological disorders, overactive bladder, and chronic health conditions such as diabetes, obesity, and urinary incontinence. The region's older population is expanding due to changing demographics and increasing life expectancy, leading to a rise in demand for adult diapers. E-commerce giants are capitalizing on this trend by offering a wide range of incontinence products, including disposable diapers and panties, for convenient online purchasing. The market is also witnessing a shift towards biodegradable and eco-friendly adult diapers made from plant-based ingredients, such as wood pulp and cotton, to address environmental concerns.
Absorbent materials and odor control are key features driving the market's growth, with advancements in technology leading to improved product performance and comfort. Additionally, the market is witnessing an increasing demand for adult diapers designed for fecal incontinence and bowel movements.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Distribution Channel

  Online
  Offline


Product

  Pad type
  Flat type
  Pant type


Geography

  Middle East and Africa

    Egypt

By Distribution Channel Insights

The online segment is estimated to witness significant growth during the forecast period.

The market caters to the geriatric population and individuals with incontinence, neurological disorders, and mobility impairment. Incontinence absorbent products, including adult diapers, are in high demand due to chronic health conditions such as urinary incontinence, diabetes, and obesity. E-commerce giants have recognized this trend and are expanding their offerings to include adult diapers. Consumers prefer cash-on-delivery (COD) for online purchases due to concerns over online payment platforms. Key payment gateway service providers facilitate secure transactions. Biodegradable adult diapers made from plant-based ingredients and non-woven materials are gaining popularity due to environmental concerns.

The market includes various product types, such as tab-style briefs, pull-on underwear, booster pads, and adult diaper pants, catering to both male and female segments. Online sales channels offer convenience, hygiene, dignity, comfort, and confidence to adults dealing with incontinence.

Get a glance at the market share of various segments Request Free Sample

The online segment was valued at USD 245.40 million in 2018 and showed a gradual increase during the forecast period.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Middle East and Africa Adult Diapers Market?

Growing awareness and adoption in developing countries is the key driver of the market.

The market caters to the growing needs of the geriatric population and individuals with neurological disorders, incontinence, and mobility impairment. Incontinence absorbent p

According to Cognitive Market Research, the global Non-alcoholic Beverages and Soft Drinks Market was valued at approximately USD XX billion in 2025 and is expected to grow to USD XX billion by 2031, expanding at a CAGR of XX% during the forecast period.

North America held largest share of XX% in the year 2025. Europe held share of XX% in the year 2025. Asia-Pacific held significant share of XX% in the year 2025. South America held significant share of XX% in the year 2025. Middle East and Africa held significant share of XX% in the year 2025. Market Dynamics

Key Drivers

Increasing health awareness among consumers id driving market growth

Increasing health awareness is a key driver of growth in the non-alcoholic beverage market, as more consumers become more conscious of the impact of alcoholic beverages on their health and lifestyle. There is also a shift in preference towards functional beverages made with natural ingredients rather than artificial additives and preservatives. Wellness tea products, particularly those with functional benefits, experienced a major surge in demand during the global COVID-19 pandemic, as well as tea in general for health benefits and self-care. More people are turning to tea over other beverages not just for its soothing qualities but also for its targeted health benefits such as immunity support, stress relief and improved digestive health.

Younger consumers are more likely to accept non-alcoholic products since they are concerned about their health and wellness. Both millennials and Gen Z are more inclined to choose alcohol-free beverages during social gatherings and events, motivated by a desire to avoid the negative effects of alcohol while maintaining the experience. As fitness continues to trend globally, athletes and fitness-conscious individuals have become a significant demographic for functional non-alcoholic beverages. These drinks include hydrating waters, protein-packed smoothies, and energy drinks, which support athletic performance and recovery.

(Source:https://foodnbeveragesprocessing.com/non-alcoholic-beverages-a-booming-industry-across-global-markets/ )

RESTRAINTS

Regulatory pressures to curb sugar content is significantly restraining market growth

Most soft drinks contain high amounts of sugar. Regulatory pressures are a significant restraint on the global non-alcoholic beverage market as governments around the world are implementing strict policies across health and environmental aspects. One of the most impactful regulations is the imposition of sugar tax aimed at curbing health related issues like obesity and diabetes. Countries like India, the UK, Mexico and Saudi Arabia have introduced sugar sweetened beverage taxes. Leading to higher production costs and retail prices leading to a potential decrease in demand, particularly in price-sensitive markets.

OPPORTUNITY

The growing demand for healthier alternatives to sugary drinks, rising consumer awareness of health and awareness and development of beverages incorporating ingredients like vitamins, minerals, probiotics or plant extracts to support various body functions is significantly driving demand for functional beverages. More individuals are putting their health and wellness first, which is fueling the popularity of functional beverages that help them achieve certain health objectives.

For instance, consumers are looking for multi-functional drinks with 69% of U.S. functional drink consumers agreeing functional drinks should have multiple functional ingredients.

(Source:https://www.bevindustry.com/articles/97136-functional-beverage-market-expands-to-meet-consumer-expectations ) Introduction to Non-aclcoholics beverages and Soft Drinks Market

The Non-alcoholic Beverages and Soft Drinks market includes all drinks that do not contain alcohol, offering a wide range of drinks such as, bottled water, carbonated soft drinks, juices, sports and energy drinks, tea, coffee and plant-based beverages. Such drinks are most often consumed for hydration, refreshment and even health purposes. The increase in demand for healthier and low-sugar alternatives due to rising awareness around health and wellness, is driving growth for products like flavored water, cold brew coffee, kombucha and herbal teas. The global non alcoholic beverages market is dynamic and competitive, driven by innovation in flavors, packaging and functional ingr...